Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, developing as a continuum, and progressing from the initial insult (underlying …

Background Cardiogenic shock (CS) and low cardiac output syndrome (LCOS) as
complications of acute myocardial infarction (AMI), heart failure (HF) or cardiac surgery are …

Abstract Disclaimer: The Extracorporeal Life Support Organization (ELSO) Coronavirus
Disease 2019 (COVID-19) Guidelines have been developed to assist existing …

Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Background It is currently unclear if active left ventricular (LV) unloading should be used as
a primary treatment strategy or as a bailout in patients with cardiogenic shock (CS) treated …

Myocarditis is an inflammatory disease of the myocardium with a broad spectrum of clinical
presentations, ranging from mild symptoms to severe heart failure. The course of patients …

Background: Limited progress has been made in the management of cardiogenic shock
(CS). Morbidity and mortality of refractory CS remain high. The effects of mechanical …

Purpose This study aimed to concisely describe the current standards of care, major recent
advances, common beliefs that have been contradicted by recent trials, areas of uncertainty …

Rationale: Identification of cardiogenic shock severity is a critical step to adapt the
management level upon admission. Peripheral tissue perfusion signs, simple and reliable …